Literature DB >> 15832771

Comparison of four different assays for determination of serum S-100B.

L H M Smit1, C M Korse, J M G Bonfrer.   

Abstract

BACKGROUND: S-100B determination has been shown to be clinically useful in the management of melanoma patients. After the development of a test for determination of the isoforms S100-A1B and S100-BB in serum (S-100B), several sensitive assays for the detection of serum S-100B have become available. We compared four S-100B assays, two automated (LIAISON Sangtec 100 and Elecsys S100) and two manual ones (Sangtec 100 ELISA and CanAg S100 EIA), with respect to clinical data, reference values and correlation.
METHODS: In a total of 280 samples from 155 melanoma patients and 98 healthy individuals S-100B values were measured simultaneously with the different assays.
RESULTS: The inter and intra coefficients of variation were best for the automated assays. The functional sensitivity of both manual assays was 0.15 microg/L. Method comparison revealed satisfactory correlation coefficients of 0.9 or higher, but the slopes ranged from 0.29 to 3.36. Except for the Sangtec 100 ELISA, the linearity between the assays was acceptable. The overall sensitivity for melanoma ranged from 37% (Elecsys S100) to 47% (LIAISON Sangtec 100) and the sensitivity increased with stage. ROC curves showed the best accuracy for the LIAISON Sangtec 100 assay.
CONCLUSIONS: All assays gave satisfactory results, but it is advisable to improve the performance of the manual assays for better sensitivity. Agreement about an international reference standard is needed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15832771     DOI: 10.1177/172460080502000106

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   3.248


  20 in total

1.  Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694.

Authors:  Ahmad A Tarhini; Joseph Stuckert; Sandra Lee; Cindy Sander; John M Kirkwood
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

2.  Tumour assessment in advanced melanoma: value of FDG-PET/CT in patients with elevated serum S-100B.

Authors:  Klaus Strobel; Jeannine Skalsky; Victor Kalff; Katrin Baumann; Burkhardt Seifert; Helen Joller-Jemelka; Reinhard Dummer; Hans C Steinert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03-28       Impact factor: 9.236

3.  Prognostic value of serum s100 protein by elecsys s100 immunoassay in patients with spontaneous subarachnoid and intracerebral hemorrhages.

Authors:  Seok-Mann Yoon; Young-Jin Choi; Hwi-Jun Kim; Jai-Joon Shim; Hack-Gun Bae; Il-Gyu Yun
Journal:  J Korean Neurosurg Soc       Date:  2008-11-30

4.  Secondary peaks of S100B in serum relate to subsequent radiological pathology in traumatic brain injury.

Authors:  Eric P Thelin; David W Nelson; Bo-Michael Bellander
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

5.  Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma.

Authors:  Barbara Peric; Ivana Zagar; Srdjan Novakovic; Janez Zgajnar; Marko Hocevar
Journal:  BMC Cancer       Date:  2011-08-02       Impact factor: 4.430

6.  Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light.

Authors:  Faiez Al Nimer; Eric Thelin; Harriet Nyström; Ann M Dring; Anders Svenningsson; Fredrik Piehl; David W Nelson; Bo-Michael Bellander
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

7.  Predicting brain metastases of breast cancer based on serum S100B and serum HER2.

Authors:  Troels Bechmann; Jonna Skov Madsen; Ivan Brandslund; Erik Dalsgaard Lund; Tina Ormstrup; Erik Hugger Jakobsen; Anne Marie Bak Jylling; Karina Dahl Steffensen; Anders Jakobsen
Journal:  Oncol Lett       Date:  2013-08-19       Impact factor: 2.967

Review 8.  S-100B and neuron-specific enolase as predictors of neurological outcome in patients after cardiac arrest and return of spontaneous circulation: a systematic review.

Authors:  Koichiro Shinozaki; Shigeto Oda; Tomohito Sadahiro; Masataka Nakamura; Yo Hirayama; Ryuzo Abe; Yoshihisa Tateishi; Noriyuki Hattori; Tadanaga Shimada; Hiroyuki Hirasawa
Journal:  Crit Care       Date:  2009-07-22       Impact factor: 9.097

Review 9.  Reliability of S100B in predicting severity of central nervous system injury.

Authors:  Stephen M Bloomfield; James McKinney; Les Smith; Jonathan Brisman
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.532

10.  Markers of cerebral damage during delirium in elderly patients with hip fracture.

Authors:  Barbara C van Munster; Catharina M Korse; Sophia E de Rooij; Johannes M Bonfrer; Aeilko H Zwinderman; Johanna C Korevaar
Journal:  BMC Neurol       Date:  2009-05-27       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.